TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -3 | -8 | -15 | -26 | -48 | -68 | -28 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/14 16:01 | 2/10/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | S.d | -470 | 62.61 | 33 | -8 | -56 | 6 | D | 290 | 149 | -30 | -6 | -8 | 7 | 10 | 14 | -2 | -5 | -23 | -49 | -54 | -62 |
11/13/13 17:31 | 11/11/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | S.d | -593 | 79.04 | 33 | -8 | -56 | 6 | D | 458 | 283 | 72 | -12 | -15 | -9 | -2 | 14 | -4 | -20 | -21 | -22 | -61 | -75 |
8/16/13 16:56 | 8/14/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | S.d | -701 | 93.44 | 33 | -8 | -94 | 1 | D | 526 | 514 | 202 | 41 | 23 | 11 | -5 | -7 | -3 | 0 | -2 | -8 | -30 | -68 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |